Krom RA - Search Results

1

An open-label study of the safety and tolerability of converting stable liver transplant recipients to neoral.

Pasha TM, Wiesner RH, Dahlke LM, Porayko MK, Krom RA. Pasha TM, et al. Among authors: krom ra. Liver Transpl Surg. 1998 Sep;4(5):410-5. doi: 10.1002/lt.500040507. Liver Transpl Surg. 1998. PMID: 9724479 Free article. Clinical Trial.

2

Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.

Charatcharoenwitthaya P, Pimentel S, Talwalkar JA, Enders FT, Lindor KD, Krom RA, Wiesner RH. Charatcharoenwitthaya P, et al. Among authors: krom ra. Liver Transpl. 2007 Sep;13(9):1236-45. doi: 10.1002/lt.21124. Liver Transpl. 2007. PMID: 17763401 Free article.

3

Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts.

Batts KP, Moore SB, Perkins JD, Wiesner RH, Grambsch PM, Krom RA. Batts KP, et al. Among authors: krom ra. Transplantation. 1988 Feb;45(2):376-9. doi: 10.1097/00007890-198802000-00026. Transplantation. 1988. PMID: 3278430

4

Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression.

Wijdicks EF, Wiesner RH, Krom RA. Wijdicks EF, et al. Among authors: krom ra. Neurology. 1995 Nov;45(11):1962-4. doi: 10.1212/wnl.45.11.1962. Neurology. 1995. PMID: 7501141

5

Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation.

Porayko MK, Textor SC, Krom RA, Hay JE, Gores GJ, Richards TM, Crotty PH, Beaver SJ, Steers JL, Wiesner RH. Porayko MK, et al. Among authors: krom ra. Mayo Clin Proc. 1994 Feb;69(2):105-11. doi: 10.1016/s0025-6196(12)61034-9. Mayo Clin Proc. 1994. PMID: 7508536 Clinical Trial.

6

Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissue.

Sandborn WJ, Lawson GM, Cody TJ, Porayko MK, Hay JE, Gores GJ, Steers JL, Krom RA, Wiesner RH. Sandborn WJ, et al. Among authors: krom ra. Hepatology. 1995 Jan;21(1):70-6. Hepatology. 1995. PMID: 7528712 Clinical Trial.

7

Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.

Porayko MK, Textor SC, Krom RA, Hay JE, Gores GJ, Wahlstrom HE, Sanchez-Urdazpal L, Richards T, Crotty P, Beaver S, et al. Porayko MK, et al. Among authors: krom ra. Transplant Proc. 1993 Feb;25(1 Pt 1):665-8. Transplant Proc. 1993. PMID: 7679835 Clinical Trial. No abstract available.

8

Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients.

Textor SC, Wiesner R, Wilson DJ, Porayko M, Romero JC, Burnett JC Jr, Gores G, Hay E, Dickson ER, Krom RA. Textor SC, et al. Among authors: krom ra. Transplantation. 1993 Jun;55(6):1332-9. doi: 10.1097/00007890-199306000-00023. Transplantation. 1993. PMID: 7685934 Clinical Trial.

9

Intracerebral hemorrhage in liver transplant recipients.

Wijdicks EF, de Groen PC, Wiesner RH, Krom RA. Wijdicks EF, et al. Among authors: krom ra. Mayo Clin Proc. 1995 May;70(5):443-6. doi: 10.4065/70.5.443. Mayo Clin Proc. 1995. PMID: 7731253

10

Treatment of early cellular rejection following liver transplantation with intravenous methylprednisolone. The effect of dose on response.

Wiesner RH, Ludwig J, Krom RA, Steers JL, Porayko MK, Gores GJ, Hay JE. Wiesner RH, et al. Among authors: krom ra. Transplantation. 1994 Nov 15;58(9):1053-6. doi: 10.1097/00007890-199411150-00015. Transplantation. 1994. PMID: 7974734 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters